BIOVENTUS INC

Ticker: BVS CUSIP: 09075A108 Class: Common Stock

MARSHALL WACE, LLP's Holding History (CIK: 0001318757)

Note: Option positions (PUT/CALL) are excluded.

Q4 2025
Shares 288,900 Value ($000) $2,149 Avg Close $7.19 Range $6.37 - $8.26
Q3 2025
Shares 287,619 Value ($000) $1,924 Avg Close $6.94 Range $5.81 - $7.74
Q2 2025
Shares 211,695 Value ($000) $1,401 Avg Close $7.09 Range $6.02 - $9.56
Q1 2025
Shares 159,744 Value ($000) $1,462 Avg Close $9.99 Range $8.43 - $11.25
Q4 2024
Shares 73,423 Value ($000) $771 Avg Close $11.83 Range $7.30 - $14.38
Q3 2024
Shares 380,827 Value ($000) $4,551 Avg Close $8.65 Range $5.47 - $12.41
Q2 2024
Shares 332,291 Value ($000) $1,911 Avg Close $5.49 Range $3.90 - $7.04
Q1 2024
Shares 240,448 Value ($000) $1,250 Avg Close $4.89 Range $4.28 - $6.08
Q4 2023
Shares 190,635 Value ($000) $1,005 Avg Close $3.96 Range $2.85 - $5.54
Q3 2023
Shares 264,949 Value ($000) $874 Avg Close $3.51 Range $2.71 - $5.09
Q2 2023
Shares 70,771 Value ($000) $205 Avg Close $1.92 Range $0.86 - $3.81
Q1 2022
Shares 10,440 Value ($000) $147 Avg Close $13.39 Range $11.40 - $15.57
Q4 2021
Shares 175,191 Value ($000) $2,539 Avg Close $14.22 Range $11.89 - $17.53
Q1 2021
Shares 20,756 Value ($000) $317 Avg Close $14.24 Range $10.74 - $19.51